NCT05854069 is a NA clinical trial of FAMS-T1D in Type 1 Diabetes, sponsored by Vanderbilt University Medical Center.

Who is sponsoring NCT05854069?

NCT05854069 is sponsored by Vanderbilt University Medical Center.

What drugs are being tested in NCT05854069?

Interventions in NCT05854069: FAMS-T1D, Digital resources for diabetes.

What condition does NCT05854069 study?

NCT05854069 studies Type 1 Diabetes.

Is NCT05854069 still recruiting?

NCT05854069 is currently active, enrolled. Last updated 29 October 2025.

Last reviewed 2025-10-29 · How we verify

NCT05854069

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

Active, enrolled NA Last updated 29 October 2025

What this trial tests

NA trial testing FAMS-T1D in Type 1 Diabetes in 140 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

30 April 2023

Primary endpoint
31 January 2027

30 April 2027

Quick facts

Lead sponsor	Vanderbilt University Medical Center
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	140
Start date	30 April 2023
Primary completion	31 January 2027
Estimated completion	30 April 2027
Sites	2 locations across United States

Drugs / interventions tested

FAMS-T1D
Digital resources for diabetes

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 18 to 24, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the efficacy of an adapted FAMS (Family/friend Activation to Motivate Self-care) intervention on CGM use among study participants who are CGM users. We will leverage the infrastructure of an NIDDK-funded RCT evaluating FAMS-T1D among N=280 emerging adults with T1D who have elevated hemoglobin A1c or elevated diabetes distress (NCT05820477). We anticipate at least 50% using CGM to be included in these analyses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of FAMS-T1D

Trials testing the same drug.

NCT05820477 — FAMS-T1D Self-Regulation and Social Support for T1D · NA · active not recruiting

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05854069 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
Last refreshed: 29 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05854069.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing